Viewing Study NCT02792803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-02-23 @ 4:31 AM
Study NCT ID: NCT02792803
Status: UNKNOWN
Last Update Posted: 2017-07-26
First Post: 2016-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma
Sponsor: Dr. David Yan
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None POAG View
None Primary Open Angle Glaucoma View
None Ocular Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None POAG View
None Primary open angle glaucoma View
None Ocular Hypertension View
None Xalatan View
None Latanoprost View
None Ocular Hyperemia View
None IOP View
None Intraocular Pressure View
None Allergan View
None prostaglandin View